Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
Pharma
Lilly dives deep into Foundayo's cardio perks in T2D, obesity
The data represent the deepest look so far at Foundayo’s cardiovascular potential in patients with type 2 diabetes and obesity.
Fraiser Kansteiner
Oct 1, 2026 11:38am
Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan
Sep 29, 2026 11:20am
Lilly nabs weekly insulin nod from FDA in new challenge to Novo
Sep 25, 2026 8:57am
FDA approves Lilly's Mounjaro to reduce risk of cardio events
Aug 28, 2026 10:52am
Dr. Reddy's temporarily pauses generic semaglutide supplies
Jul 9, 2026 8:48am
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
Jun 8, 2026 3:42pm
